Background: The coronary angiography-derived index of microcirculatory resistance (caIMR) is a novel noninvasive method to assess coronary microvascular dysfunction (CMD). However, the association between caIMR and the prognosis of patients with dilated cardiomyopathy (DCM) is unclear. We aimed to explore the role of the caIMR in evaluating the outcome of patients with DCM.
Methods: We consecutively and retrospectively enrolled patients with DCM in the Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China, from January 2013 to January 2018. The caIMR was calculated for eligible patients. The primary end point in this study was composite events, including rehospitalization related to heart failure (HF), device implantation, heart transplantation, or cardiac death. Patients were categorized into groups based on whether they had composite events (the events and no-events groups), and differences in the baseline and end points between these two groups were analyzed.
Results: A total of 95 eligible patients with DCM were enrolled in the study, 36 of whom had end point events. The best cutoff values of the caIMR for the left anterior descending (LAD) artery, left circumflex (LCX) artery, and right coronary artery (RCA) were >29.8 with an area under the curve (AUC) of 0.828, >25.5 with an AUC of 0.720, and >29.7 with an AUC of 0.717, respectively (all P values <0.001). Patients were then classified into the higher caIMR group and the lower caIMR group based on the cutoff value. Kaplan-Meier analyses showed that patients with a higher caIMR had increased cumulative risks of end point events regardless of the cutoff values for the LAD, LCX, and RCA (all log-rank P values <0.001). After adjustment for confounders, Cox regression analyses indicated that LAD-caIMR was an independent risk factor for end point events in patients with DCM [hazard ratio (HR) =1.11; 95% CI: 1.06-1.16].
Conclusions: A higher caIMR was significantly associated with the poor prognosis of patients with DCM.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102743 | PMC |
| http://dx.doi.org/10.21037/qims-22-1060 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Evaluation and clinical applicability of angiography-derived assessment of coronary microcirculatory resistance: a [O]HO PET study.
Int J Cardiovasc Imaging
December 2024
Departments of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
The introduction of wire-free microcirculatory resistance index from functional angiography (angio-IMR) promises swift detection of coronary microvascular dysfunction, however it has not been properly validated. We sought to validate angio-IMR against invasive IMR and PET derived microvascular resistance (MVR). Moreover, we studied if angio-IMR could aid in the detection of ischemia with non-obstructive coronary arteries (INOCA).
View Article and Find Full Text PDFComparison of a Fully Angiography-Derived Versus a Hybrid of Angiography and Pressure-Wire-Derived Approach to Assess Coronary Microvascular Resistance: The Oxford Acute Myocardial Infarction Hybrid (OxAMI-HYBRID) Study.
Catheter Cardiovasc Interv
January 2025
Oxford Heart Centre, Oxford University Hospitals NHS Trust, Oxford, UK.
Article Synopsis
- The study explores the assessment of coronary microvascular dysfunction (CMD) using a new hybrid index derived from pressure-wire measurements and angiography, promoting its potential use in clinical settings.
- Researchers compared this hybrid index, known as IMR, with a traditional bolus thermodilution-based index in a cohort of patients with acute coronary syndrome and stable coronary artery disease.
- Results indicate that both the new hybrid IMR and the traditional index showed strong correlations and diagnostic accuracy for CMD, suggesting IMR is a simpler and effective alternative for routine clinical use.
Association between the plasma ceramide and coronary microvascular resistance.
Cardiovasc Diabetol
November 2024
Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, People's Republic of China.
Article Synopsis
- Plasma ceramide levels are thought to play a significant role in coronary microvascular dysfunction, but their exact relationship with coronary microvascular resistance is not well understood.
- This study analyzed data from 225 patients who underwent ceramide measurement and coronary angiography to determine how ceramide levels and their ratios relate to microvascular resistance in coronary arteries.
- Findings revealed that higher levels of ceramide 16:0 and the ratio of ceramide 16:0 to 24:0 were positively associated with increased coronary microvascular resistance, suggesting that ceramide levels may serve as predictive markers for this condition.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!